Gang Wang

Director/Board Member at SHANGHAI JUNSHI BIOSCIENCES CO., LTD.

67 year

Health Technology

Consumer Services

Profile

Gang Wang is currently an Executive Director at Shanghai Junshi Biosciences Co., Ltd., an Independent Director at Hrain Biotechnology Co., Ltd., and an Independent Director at Obio Technology Shanghai Corp.
Ltd.
Dr. Wang obtained a doctorate degree from Dartmouth Medical School in 1995.

Gang Wang active positions

Companies	Position	Start
SHANGHAI JUNSHI BIOSCIENCES CO., LTD.	Director/Board Member	19/10/2023
OBIO TECHNOLOGY (SHANGHAI) CORP., LTD.	Director/Board Member	28/12/2020
Hrain Biotechnology Co., Ltd. Hrain Biotechnology Co., Ltd. BiotechnologyHealth Technology Hrain Biotechnology Co., Ltd. engages in the research and development, and production of immune cell therapy products. It offers chimeric antigen receptor (CAR) T-cell therapy, chimeric antigen receptor-transduced natural killer (CAR-NK) cell therapy, dash chimeric antigen receptor (CAR) T-cell therapy. The company was founded by Pin Wang on July 20, 2015 and is headquartered in Shanghai, China.	Director/Board Member	17/06/2021

All active positions of Gang Wang

Training of Gang Wang

Dartmouth Medical School

Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Gang Wang's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	2
SHANGHAI JUNSHI BIOSCIENCES CO., LTD.	Health Technology
OBIO TECHNOLOGY (SHANGHAI) CORP., LTD.	Health Technology

Private companies	1
Hrain Biotechnology Co., Ltd. Hrain Biotechnology Co., Ltd. BiotechnologyHealth Technology Hrain Biotechnology Co., Ltd. engages in the research and development, and production of immune cell therapy products. It offers chimeric antigen receptor (CAR) T-cell therapy, chimeric antigen receptor-transduced natural killer (CAR-NK) cell therapy, dash chimeric antigen receptor (CAR) T-cell therapy. The company was founded by Pin Wang on July 20, 2015 and is headquartered in Shanghai, China.	Health Technology